Microdosing

Amazon's latest acquisition of One Medical is another example of the constant momentum it's bringing into healthcare.  I highlight how Amazon's entry into healthcare is showing greater potential than other non-healthcare players who are trying to break in.

While the healthcare community was chastising IBM for its Watson for Oncology solution last decade, what happened to the amazing healthcare data companies they acquired?  Well, they were set free this year, under the brand, Merative.  And what can we learn from the Watson Health days?

GE is in the process of splitting into three companies.  We explore why this is a good thing, and why it needs to be done.  

Jamil Rivers of Chrysalis Initiative talks outcome disparities within breast cancer, and striving to ensure every patient receives the care they deserve.

Donna Walthall of Dana Farber shares her ASCO observations as a fifteen-time attendee, celebrating Dana-Farber’s 75th anniversary

Tim Wolfe of Syapseshare their approach toward Real World Care and Applied Experience

Matthew Schulz, a Medical Science Liaison, shares his observations on this year’s ASCO session.

Chakra Chennubhotlaand Dusty Majumdar of SpIntellx explore the possibilities of empowering researchers and clinicians to unravel the hidden connections in the tumor microenvironment through deep profiling cell-cell communication patterns and spatial relationships.

Anthony Giordano of Sermo shares their latest efforts with the Oncologist community, as well as the impact of their "Run with Peter" charity that is funding cancer research.

Natalie Sacarakis of IQVIA shares how their Cell and Gene Therapy COE can address the unique logistics management and clinical operations challenges around one's CAGT asset and pipeline.